1. Home
  2. MHF vs STXS Comparison

MHF vs STXS Comparison

Compare MHF & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Municipal High Income Fund Inc.

MHF

Western Asset Municipal High Income Fund Inc.

HOLD

Current Price

$6.78

Market Cap

153.4M

Sector

Finance

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.89

Market Cap

182.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHF
STXS
Founded
1988
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.4M
182.3M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
MHF
STXS
Price
$6.78
$1.89
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
58.0K
398.7K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
4.29%
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
N/A
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.61
$1.74
52 Week High
$7.64
$3.59

Technical Indicators

Market Signals
Indicator
MHF
STXS
Relative Strength Index (RSI) 37.79 44.49
Support Level $6.72 $1.74
Resistance Level $7.00 $1.99
Average True Range (ATR) 0.09 0.10
MACD -0.01 -0.00
Stochastic Oscillator 0.00 18.97

Price Performance

Historical Comparison
MHF
STXS

About MHF Western Asset Municipal High Income Fund Inc.

Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: